Development of the nonreceptor tyrosine kinase FER-targeting PROTACs as a potential strategy for antagonizing ovarian cancer cell motility and invasiveness-Reference-Cited by-同舟云学术

Development of the nonreceptor tyrosine kinase FER-targeting PROTACs as a potential strategy for antagonizing ovarian cancer cell motility and invasiveness

Published:2023-06 Issue:6 Volume:299 Page:104825
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Zhang Yanchun,Xiong Xuexue,Sun Renhong,Zhu Xiaotong,Wang Chen,Jiang Biao,Yang Xiaobao,Li Dake,Fan Gaofeng^ORCID

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference57 articles.

1. Cancer statistics, 2020;Siegel;CA Cancer J. Clin.,2020

2. Maintenance therapy in ovarian cancer: molecular basis and therapeutic approach;Binaschi;Exp. Ther. Med.,2011

3. Closing in on the biological functions of Fps/Fes and fer;Greer;Nat. Rev. Mol. Cell Biol.,2002

4. FES/FER kinase signaling in hematopoietic cells and leukemias;Craig;Front. Biosci. (Landmark Ed.),2012

5. F-BAR family proteins, emerging regulators for cell membrane dynamic changes-from structure to human diseases;Liu;J. Hematol. Oncol.,2015

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of a first-in-class protein degrader for the c-ros oncogene 1 (ROS1);Bioorganic Chemistry;2024-09

2. PROTACs in Ovarian Cancer: Current Advancements and Future Perspectives;International Journal of Molecular Sciences;2024-05-07

3. Journey of Von Hippel-Lindau (VHL) E3 ligase in PROTACs design: From VHL ligands to VHL-based degraders;European Journal of Medicinal Chemistry;2024-02

4. Unraveling role of ubiquitination in drug resistance of gynecological cancer;American Journal of Cancer Research;2024

5. The Recurrent Liver MAN2A1-FER Oncoprotein Lacks Kinase Activity: Implications for the Use of Tyrosine Kinase Inhibitors;Cellular and Molecular Gastroenterology and Hepatology;2023-12